hydroxychloroquine
WHO hits ‘pause’ on trial
The international health organisation has temporarily suspended the hydroxychloroquine arm within its COVID-19 treatment trial in light of recent findings World Health Organization director-general Tedros Adhanom Ghebreyesus has confirmed the …
‘Urgent confirmation from randomised clinical trials is needed.’
A large observational study has linked hydroxychloroquine and chloroquine use to increased rates of mortality and heart arrhythmias in hospitalised COVID-19 patients A large observational study published in The Lancet has …
The week in review
COVID-19-related issues like hydroxychloroquine were still making headlines this week, but the sector was also looking to the post-pandemic future The Pharmacy Guild‘s Suzanne Greenwood wrote about the issues the …
‘Please do not follow the lead of the President of the United States.’
Following the latest remarks from the President of the United States regarding hydroxychloroquine, the RACGP has urged Australians not to seek it out to try and cure or prevent COVID-19 …
Docs should resist hydroxychloroquine temptation, say experts
Doctors shouldn’t prescribe hydroxychloroquine for family and friends to treat COVID-19, write a group of authors including prominent pharmacists In Australian Prescriber the authors, who include Associate Professor Ian Coombes, …
Advisers to government ‘cautiously hopeful’ of COVID-19 treatment
The Federal Health Minister has ‘struck a deal’ with suppliers to bring hydroxychloroquine into Australia to treat hospital patients infected with COVID-19 Speaking on A Current Affair this week, Federal …
Emergency use of drugs authorised for COVID-19
US to allow hydroxychloroquine and chloroquine from national stockpile to be distributed and used for certain hospitalised patients infected with COVID-19 The Food and Drug Administration (FDA) in the United …
New restrictions for hydroxychloroquine
The Department of Health has placed new restrictions on hydroxychloroquine initiation after a spate of ‘just in case’ overprescribing for COVID-19, and warned against use outside of current indications after …
Call to halt hydroxychloroquine prescribing, dispensing for COVID-19
PSA strongly advises pharmacists to refuse dispensing of hydroxychloroquine outside of approved indications, and urges prescribers to stop writing prescriptions as a ‘just in case’ measure Following President Trump’s announcement …